ICD-9 Code V45.02 Automatic implantable cardiac defibrillator in situ. ICD-9 Index; Chapter: E; Section: V40-V49; Block: V45 Other postsurgical states; V45.02 - Status autm crd dfbrltr
defibrillator, automatic implantable cardiac (with synchronous cardiac pacemaker) V45.02 V45.01 ICD9Data.com V45.09 ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM V45.02 is one of thousands of ICD-9-CM codes used in healthcare.
Billable Medical Code for Automatic Implantable Cardiac Defibrillator in Situ Diagnosis Code for Reimbursement Claim: ICD-9-CM V45.02. Code will be replaced by October 2015 and relabeled as ICD-10-CM V45.02. The Short Description Is: Status autm crd dfbrltr. Known As
Automatic implantable cardiac defibrillator in situ (V45.02) ICD-9 code V45.02 for Automatic implantable cardiac defibrillator in situ is a medical classification as listed by WHO under the range -PERSONS WITH A CONDITION INFLUENCING THEIR HEALTH STATUS (V40-V49). Subscribe to Codify and get the code details in a flash.
Defibrillator is also known as automatic implantable cardiac defibrillator, biventricular automatic implantable cardioverter defibrillator present, biventricular implanted defibrillator normal function, cardiac defibrillator in situ, presence of AICD, presence of biventricular AICD, presence of biventricular implantable cardiac defibrillator, and presence of cardiac defibrillator..
A defibrillator is a medical device that is used to “jump start” a person’s heart using electrical shock. The different types of defibrillators are automated external defibrillator (AED) and sudden cardiac arrest (SCA). Defibrillators are used for cardiac arrest, heart attacks, and if the heart stops working properly.
Although Medicare’s NCD provides coverage criteria for primary and secondary prevention of sudden death, the coverage of the two indications is not the same.#N#Secondary prevention of sudden death is covered, as long as there are no contraindications. Medicare only covers ICDs placed for the primary prevention of sudden cardiac death if data is submitted to an FDA-approved category B IDE clinical trial, a trial under the CMS Clinical Trial Policy, or a qualifying data collection system, including approved clinical trials and registries. CMS selected the American College of Cardiology’s National Cardiovascular Data Registry (ACC-NCDR) ICD Registry as the mandated national registry for ICDs in October 2005. The ClinicalTrials.gov identifier for this data repository is NCT01999140.#N#When an ICD is implanted in the outpatient setting, providers notify Medicare that data is being submitted to the ACC-NCDR, as required in the NCD, by appending modifier Q0 Investigational clinical service provided in a clinical research study that is in an approved clinical research study to the CPT® code for the implantation procedure. If the performed procedure is for primary prevention of sudden death, and modifier Q0 is not appended, there is no coverage for the ICD implantation.#N#Modifier Q0 is required only when the ICD is implanted for primary prevention of sudden death. Modifier Q0 may be appended to claims for secondary prevention indications (those meeting non-restricted coverage requirements due to clinical indications) when data is being submitted to a data collection system.#N#Although the ACC-NCDR may not meet the expected definition of a clinical trial, the use of modifier Q0 categorizes the procedure as part of a clinical study. When a clinical study is performed, ICD-10-CM Z00.6 Encounter for examination for normal comparison and control in clinical research program typically is required in either the primary or secondary position on the claim.#N#The following items are required when billing for ICDs implanted for primary prevention of sudden death:#N#For hospital outpatient billing, clinical trial registry number 1999140 in the electronic claim equivalent, 837I (Loop 2300 REF02 (REF01=P4) for an 837I claim when a clinical trial claim includes:
Medicare only covers ICDs placed for the primary prevention of sudden cardiac death if data is submitted to an FDA-approved category B IDE clinical trial, a trial under the CMS Clinical Trial Policy, or a qualifying data collection system, including approved clinical trials and registries.
The coverage falls into two major categories: primary prevention of sudden cardiac death and secondary prevention of sudden cardiac death. Primary prevention ICD implantation is to prevent sudden death in a patient who has poor cardiac function and potentially abnormal heart rhythm that could lead to cardiac arrest.
Ruth Broek, MBA, CIRCC, COC, CCS, RTR, CHC, vice president of ZHealth Publishing, is responsible for all support functions, including researching coverage issues, maintaining coding policies, keeping the reference library updated, and maintaining website information. She also performs chargemaster reviews and revenue cycle process improvement for facilities across the country. Broek is a member of the Murfreesboro, Tenn., local chapter.